Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

A novel subpopulation of drug-resistant myeloid-derived suppressor cells may promote the growth of tumour metastases

FY 2014-15

Summary
The metastatic spread of cancer from the location of the primary tumour to other tissues is associated with an estimated 90% of cancer-related deaths, highlighting the critical need for novel effective therapeutic strategies to treat and prevent metastatic disease. Recent studies have suggested that the primary tumour of cancer patients secretes factors that cause host immune suppressor cells to accumulate in other distant tissues. These cells locally repress the anti-tumour response of the host immune system, providing a new favourable location for metastatic cancer cells to develop. Clinical evidence has shown that the immune suppressor cells that accumulate in distant tissues of breast cancer patients are comparable to those found in mice bearing metastatic mammary tumours. We have found that these immune suppressor cells accumulate in the lung tissue of mouse models of metastatic breast cancer and persist even after the primary tumour has been removed. The goal of my research is to find unique cell surface markers that allow this resistant subset of immune suppressor cells to be used to identify patients that are at higher risk of developing metastatic disease after primary tumour resection. I then intend to design a method to systematically screen various compounds to identify specific inhibitors of these immune suppressor cells based on their unique cell surface markers. These data will have important clinical implications for breast cancer patients, as inhibiting this subset of immune suppressor cells could assist in the reduction of secondary metastatic tumour growth after primary tumour removal in the treatment of breast cancer.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331247
Name
Collier Jenna L
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
A novel subpopulation of drug-resistant myeloid-derived suppressor cells may promote the growth of tumour metastases
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Cancer Therapy; Immune Suppression; Metastasis; Myeloid-Derived Suppressor Cells; Proteomics
Abstract
The metastatic spread of cancer from the location of the primary tumour to other tissues is associated with an estimated 90% of cancer-related deaths, highlighting the critical need for novel effective therapeutic strategies to treat and prevent metastatic disease. Recent studies have suggested that the primary tumour of cancer patients secretes factors that cause host immune suppressor cells to accumulate in other distant tissues. These cells locally repress the anti-tumour response of the host immune system, providing a new favourable location for metastatic cancer cells to develop. Clinical evidence has shown that the immune suppressor cells that accumulate in distant tissues of breast cancer patients are comparable to those found in mice bearing metastatic mammary tumours. We have found that these immune suppressor cells accumulate in the lung tissue of mouse models of metastatic breast cancer and persist even after the primary tumour has been removed. The goal of my research is to find unique cell surface markers that allow this resistant subset of immune suppressor cells to be used to identify patients that are at higher risk of developing metastatic disease after primary tumour resection. I then intend to design a method to systematically screen various compounds to identify specific inhibitors of these immune suppressor cells based on their unique cell surface markers. These data will have important clinical implications for breast cancer patients, as inhibiting this subset of immune suppressor cells could assist in the reduction of secondary metastatic tumour growth after primary tumour removal in the treatment of breast cancer.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Collier, Jenna L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~